3M Company stock (US88579Y1010): shares steady after Q1 2026 update and health-care spin-off

3M Company shares on the NYSE traded broadly steady on 06/02/2026 as investors continued to digest the group’s Q1 2026 results and the completed Solventum health-care spin-off, which reshaped the US-based conglomerate’s portfolio and near-term financial profile.

3M Company shares in the United States traded broadly unchanged on the NYSE on 06/02/2026, as the market continued to assess the implications of the group’s Q1 2026 earnings release and the completed separation of its health-care business into Solventum earlier in the year, both of which are key to the current investment narrative for the Minnesota-based industrial and consumer products manufacturer, according to Reuters as of 05/15/2026.

The stock last changed hands at around USD 112 on the NYSE on 06/02/2026, after moving in a relatively narrow intraday range, while trading volumes remained close to recent averages, according to data from the New York Stock Exchange as of 06/02/2026. In Germany, the shares were also quoted on Tradegate in euros, offering local investors an alternative access point to the US-listed name, based on Tradegate pricing as of 06/02/2026.

3M said in its Q1 2026 results published on 04/26/2026 that continuing operations generated revenue of roughly USD 8 billion and adjusted earnings per share from continuing operations of about USD 2.50, reflecting the impact of the health-care spin-off and ongoing portfolio reshaping, according to the company’s Q1 2026 earnings release as of 04/26/2026. Management reiterated its full-year 2026 guidance for the remaining businesses at the time of the update, framing the period as an execution year after the structural changes, according to the same Q1 2026 release as of 04/26/2026.

The separation of the health-care business into Solventum was completed on 04/01/2024, with 3M retaining a minority stake that it plans to monetize over time, according to the company’s spin-off completion announcement as of 04/01/2024. This transaction means that the US-based group’s current financials and trading patterns on the NYSE primarily reflect its industrial, safety and consumer segments, rather than the health-care operations that historically contributed a significant share of earnings, according to the spin-off documentation filed with the SEC as of 04/01/2024.

Beyond the portfolio shift, the company has also been dealing with legacy legal matters, including settlements related to PFAS and Combat Arms earplugs, which continue to influence sentiment toward the stock in US markets, according to filings on sec.gov as of 03/15/2026. These items, while not the headline driver of day-to-day price moves on 06/02/2026, remain part of the broader backdrop that NYSE investors weigh when interpreting quarterly numbers and updated guidance.

As of: 06/02/2026

By the editorial team - specialized in equity coverage.

At a glance

• Name: 3M Company
• Sector/industry: Diversified industrial and consumer products
• Headquarters/country: Saint Paul, United States
• Core markets: North America, Europe, Asia-Pacific
• Key revenue drivers: Safety and industrial solutions, transportation and electronics, consumer products
• Home exchange/listing venue: New York Stock Exchange (MMM)
• Trading currency: USD

3M Company: core business model

Following the Solventum spin-off, 3M Company focuses on a diversified set of industrial, safety, electronics and consumer product lines, with revenue largely generated from selling engineered materials, filtration systems, adhesive solutions and branded consumer goods into global industrial and retail channels.

Latest quarterly results for 3M Company at a glance

For Q1 2026, 3M reported revenue from continuing operations of about USD 8 billion and adjusted earnings per share from continuing operations around USD 2.50, reflecting the company’s new structure after the Solventum separation, according to its Q1 2026 earnings press release as of 04/26/2026. The report highlighted that underlying demand trends were mixed across regions, with relatively stable volumes in the United States and softer activity in parts of Europe, while management reiterated its outlook for the year on the back of ongoing cost controls and portfolio simplification, based on the same Q1 2026 update as of 04/26/2026.

Within the quarter, safety and industrial products remained an important contributor to profit, while transportation and electronics showed sensitivity to end-market cycles in areas such as automotive and consumer electronics, according to the Q1 2026 presentation materials as of 04/26/2026. The consumer business, which includes well-known brands in home improvement and office supplies, continued to provide a relatively stable revenue base, even as the company executed on restructuring measures intended to streamline operations and improve margins over time, as outlined in the Q1 2026 earnings presentation as of 04/26/2026.

Conclusion

On 06/02/2026, 3M Company’s share price on the NYSE traded broadly stable as investors continued to factor in the Q1 2026 earnings metrics and the reshaped business mix following the Solventum health-care spin-off. The latest quarterly figures underline the importance of execution in the remaining industrial, safety, electronics and consumer segments, while legacy legal settlements and the planned monetization of the Solventum stake remain significant elements of the broader story that market participants monitor in the United States and beyond.

Disclaimer: This article does not constitute investment advice. The comprehensive scope of this informative article was made possible through the use of a.i.. Stocks are volatile financial instruments.